Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
University of Michigan · with National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · NCT00748254
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 113
- US sites recruiting
- 1
- Study start
- December 1, 2011
- Record last updated
- January 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.
Being studied: Laser Based Photoacoustic Tomography, MRI, Ultrasound; laser based photoacoustic tomography, MRI, ultrasound
Conditions: Arthritis, Rheumatoid
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Men and women 18 years of age or older can participate in this study.
- Patients can participate in this study if they have had rheumatoid arthritis for more than 2 years and their rheumatologist has referred them to this study.
- Patients can participate as a healthy volunteer with a known history of rheumatoid arthritis.
Exclusion Criteria
- Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
- Pregnant patients.
- Patients who is claustrophobic.
- Patients with impaired renal function cannot participate in this study such as elevate creatinine clearance, patients on kidney dialysis etc.
- Patients with shock hypotension or unstable low blood pressure.
- Patients with Rhabdomyolysis.
- Patients who have had a contrast enhanced (with gadolinium) MRA (magnetic resonance angiography)/ or MRI within the last 3 months. (Contrast is a medication injected into a vein during a imaging examination that helps produce clearer images/pictures).
Recruiting US locations
Universtity of Michigan Health System
Ann Arbor, MI 48109
Site contact: Xueding Wang, PHD
Study contacts (from the official record)
- Safa Mohamed · 734 615-1646 · safam@med.umich.edu
Similar studies in Michigan
All arthritis studies in Michigan →- RecruitingPhase 3
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Medipost, Inc.
- Location
- Ann Arbor, MI + 33 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With…
Amgen
- Location
- Lansing, MI + 73 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda
- Location
- Grand Blanc, MI + 45 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis
Enlivex Therapeutics Ltd.
- Location
- Troy, MI + 3 other US sites
- Eligibility basics
- Ages 64+